|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/436 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2462934 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12153823.5 |
| Date of filing the European patent application | 2008-04-08 | |
| (97) | Date of publication of the European application | 2012-06-13 |
| (45) | Date of publication and mention of the grant of the patent | 2016-06-08 |
| (46) | Date of publication of the claims translation | 2016-08-10 |
| (30) | Number | Date | Country code |
| 922759 P | 2007-04-10 | US |
| (72) |
Dukart, Gary, US
Gibbons, James, Joseph, Jr., US
Berkenblit, Anna, US
Feingold, Jay, Marshall, US
|
| (73) |
Wyeth LLC,
235 East 42nd Street, New York, NY 10017-5755,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Temsirolimuso priešnavikinis aktyvumas papilinių inkstų ląstelių vėžio atveju |
| Anti-tumor activity of temsirolimus in papillary renal cell cancer |
| Payment date | Validity (years) | Amount | |
| 2018-03-28 | 11 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2018-06-30 |